Document Detail


Differential dopaminergic modulation of executive control in healthy subjects.
MedLine Citation:
PMID:  15765257     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
RATIONALE: Executive control (EC) has different subcomponents, e.g., response inhibition (measured, for example, by the Stroop task) and working memory (WM-measured, for example, by delayed response tasks, DRT). EC has been associated with networks involving the prefrontal cortex (PFC). Moreover, there is evidence that dopamine agonists, especially those with a D1 profile, may modulate EC, since in the PFC D1 subtype receptors are more abundant. OBJECTIVE: This study aimed to selectively distinguish whether D1 versus D2 dopamine agonism differentially influences EC related to the inhibition of irrelevant information and WM. Because of its D1 component, we predicted that the administration of pergolide (mixed D1/D2 agonist), in comparison with bromocriptine (D2 selective agonist) and placebo, would enhance performance in both EC tasks. Using a lateralized Stroop task, we predicted a decrease in the interference effect, as well as error rates, while no increase in facilitation effects. For the DRT task, we predicted fewer error scores in the delay condition. METHODS: Forty male healthy subjects participated in this randomized, double-blind, placebo-controlled, crossover study. RESULTS: For the Stroop task no superiority of pergolide was found; however, with bromocriptine, decreased interference was found. No modulation of lateralization effects was shown in interference measures. Moreover, subjects on pergolide showed an absence of facilitation effects. No effects of either agonist were found for the DRT. CONCLUSION: Our findings suggest that dopamine agonists modulate two EC tasks differently. Furthermore, there seems to be a selective modulation of different aspects of the Stroop task.
Authors:
Daniela Roesch-Ely; Hans Scheffel; Stephan Weiland; Markus Schwaninger; Hans-Peter Hundemer; Thomas Kolter; Matthias Weisbrod
Related Documents :
7478897 - Short-term memory for color names using stroop material.
18762447 - Stroop interference and the timing of selective response activation.
18973877 - Judgments of discrete and continuous quantity: an illusory stroop effect.
3160817 - Some effects of color on naming and recognition of objects.
23375117 - Effects of chewing on cognitive processing speed.
21475717 - Authenticity anyone? the enhancement of emotions via neuro-psychopharmacology.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2004-11-18
Journal Detail:
Title:  Psychopharmacology     Volume:  178     ISSN:  0033-3158     ISO Abbreviation:  Psychopharmacology (Berl.)     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-03-14     Completed Date:  2005-10-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7608025     Medline TA:  Psychopharmacology (Berl)     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  420-30     Citation Subset:  IM    
Affiliation:
Psychiatry Hospital, University of Heidelberg, Heidelberg, Germany. daniela_roesch@med.uni-heidelberg.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adaptation, Psychological
Administration, Oral
Adult
Affect / drug effects,  physiology
Bromocriptine / administration & dosage,  pharmacokinetics
Capsules
Cross-Over Studies
Domperidone / administration & dosage,  adverse effects,  pharmacokinetics
Double-Blind Method
Drug Administration Schedule
Feedback, Psychological / drug effects*,  physiology*
Functional Laterality / physiology
Hand / physiology
Humans
Male
Pergolide / administration & dosage,  adverse effects,  pharmacokinetics
Prefrontal Cortex / drug effects,  physiology
Reaction Time / drug effects
Receptors, Dopamine D1 / agonists,  physiology*
Receptors, Dopamine D2 / agonists,  physiology*
Social Behavior
Chemical
Reg. No./Substance:
0/Capsules; 0/Receptors, Dopamine D1; 0/Receptors, Dopamine D2; 25614-03-3/Bromocriptine; 57808-66-9/Domperidone; 66104-22-1/Pergolide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-ma...
Next Document:  The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of...